AI Article Synopsis

  • This study reveals that coumarin-based nitrofuranyl calanolides (NFCs) can interact with the protein Rv2466c, creating a ternary complex that leads to enhanced fluorescence when reduced.
  • It was found that a specific fragment of the mycothiol (MSH), known as acetylated cysteine-glucosamine (AcCys-GlcN), effectively binds to Rv2466c and is crucial for the reduction of NFCs.
  • The research also suggests that the new fluorescent NFC probe could enable rapid and cost-effective detection of Mycobacterium tuberculosis, aiding in timely drug susceptibility testing for better TB treatment outcomes.

Article Abstract

Firstly, this study demonstrated that natural product-inspired coumarin-based nitrofuranyl calanolides (NFCs) can form the Rv2466c-mycothiol (MSH)-NFC (RvMN) ternary complex via NFC binding to W21, N51, and Y61 of Rv2466c and be specifically reduced by Rv2466c, which is accompanied by the generation of a high level of fluorescence. Additionally, the results unveiled that the acetylated cysteine-glucosamine (AcCys-GlcN) motif of MSH is sufficient to interact with Rv2466c and adopt the active conformation that is essential for fully reducing NFCs. Further clinical translational investigation in this Article indicated that the novel fluorescent NFC probe can serve as a much needed high-throughput and low-cost detection method for detection of living Mycobacterium tuberculosis ( Mtb) and can precisely determine MIC values for a full range of available drugs. This method can greatly facilitate the development of phenotypic drug-susceptibility testing (pDST) that will allow the point-of-care treatment of tuberculosis (TB) within a week after diagnosis.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acsinfecdis.9b00006DOI Listing

Publication Analysis

Top Keywords

mycobacterium tuberculosis
8
nitrooxidoreductase rv2466c-dependent
4
rv2466c-dependent fluorescent
4
fluorescent probe
4
probe mycobacterium
4
tuberculosis diagnosis
4
diagnosis drug
4
drug susceptibility
4
susceptibility testing
4
testing firstly
4

Similar Publications

Expanding the Chemical Space of Reverse Fosmidomycin Analogs.

ACS Med Chem Lett

January 2025

Institute of Pharmaceutical and Medicinal Chemistry, Faculty of Mathematics and Natural Sciences, Heinrich Heine University Düsseldorf, Universitätsstr. 1, 40225 Düsseldorf, Germany.

Multidrug-resistant pathogens pose a major threat to human health, necessitating the identification of new drug targets and lead compounds that are not susceptible to cross-resistance. This study demonstrates that novel reverse thia analogs of the phosphonohydroxamic acid antibiotic fosmidomycin inhibit 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXR), an essential enzyme for , , and that is absent in humans. Some novel analogs with large α-phenyl substituents exhibited strong inhibition across these three DXR orthologues, surpassing the inhibitory activity of fosmidomycin.

View Article and Find Full Text PDF

Disseminated infection in an immunocompromised adult: An uncommon etiology of skin infection.

IDCases

December 2024

Department of Medicine, Mary Washington Healthcare, Fredericksburg, VA, USA.

is a rapidly growing nontuberculous mycobacterium (NTM) that is ubiquitous in the environment and is associated with skin and soft tissue infections (1). Because is an opportunistic infection, it can present as skin abscess, cellulitis, osteomyelitis, pulmonary infection or disseminated infections, particularly in individuals with compromised immune systems or underlying lung conditions such as cystic fibrosis or bronchiectasis. is one of the most pathogenic rapidly growing mycobacteria (RGM).

View Article and Find Full Text PDF

Mixed nontuberculous mycobacteria in an immunocompromised patient with probable progressive multifocal leukoencephalopathy.

IJID Reg

March 2025

SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Human Genetics, Stellenbosch University, Cape Town, South Africa.

Objectives: Nontuberculous mycobacteria (NTM) are increasingly recognized opportunistic pathogens found ubiquitously in the environment. The presence of multiple NTM species at the site of disease complicates diagnosis and treatment.

Case And Management: A 40-year-old patient who tested positive for HIV, with an absolute clusters of differentiation 4+ T-cell count of 3 cells/µl and cryptococcaemia, presented with hemoptysis, productive cough, and weight loss.

View Article and Find Full Text PDF

Amplification-free detection of using CRISPR-Cas12a and graphene field-effect transistors.

Nanoscale

January 2025

State Key Laboratory of Molecular Engineering of Polymers, Department of Macromolecular Science, Fudan University, Shanghai 200433, China.

Current molecular tests for tuberculosis (TB), such as whole genome sequencing and Xpert /rifampicin resistance assay, exhibit limited sensitivity and necessitate the pre-amplification step of target DNA. This limitation greatly increases detection time and poses an increased risk of infection. Here, we present a graphene field-effect transistor (GFET) based on the CRISPR/Cas system for detecting .

View Article and Find Full Text PDF

Asymptomatic lung abscess of aspergillus in a female without previous lung diseases or immunocompromise: a case report.

BMC Infect Dis

January 2025

Department of Respiratory and Critical Care Medicine, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.

Background: Chronic pulmonary abscess usually results from bacterial or mycobacterium infection, but rarely from aspergillosis. Chronic pulmonary aspergillosis is usually found in a person with structural lung disease or immunocompromise. Here, we report a case of chronic lung abscess of aspergillosis without immunocompromise, structural lung diseases or even clinical symptoms.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!